Skip to main content
. 2019 Jan 2;8:212551. doi: 10.7573/dic.212551
Postmenopausal women with acute climacteric syndrome
  • Lower sexual appetite or sexual dysfunction

  • Mood swings

  • Accelerated bone loss (osteoporosis prevention during the early postmenopausal period

  • Anamnesis of premenopausal mastalgia and breast tension

  • High breast density

  • Myomas

  • Urogenital problems

Transfer from MHT to tibolone
  • Mastalgia or breast tension

  • Increased breast density with need to repeat mammography or when the mammogram is unreadable

  • Mood swings

  • Sexual appetence disorders

  • Irregular bleeding without a histopathological finding

Women without acute climacteric syndrome
  • Lowered sexual appetence

  • Mood swings

  • Osteopenia

Younger women – possible use
  • Premature ovarian failure – with sexual dysfunction and mood swings

  • Long-term add-back therapy of agonists GnRH

GnRH, gonadotropin-releasing hormone; MHT, menopause hormone therapy.